[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:nasopharyngeal-squamous-cell-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Nasopharyngeal Squamous Cell Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06532279","Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:15:59.318403Z","2026-05-05T02:43:28.872744Z",[],[]]